In a phase 2 clinical trial targeting obese individuals without type 2 diabetes (T2D), retatrutide dosed at 1 to 12 mg resulted in up to 24.2% weight loss over a 48-week treatment period, compared to 2.1% in the placebo group, and demonstrated a dose-dependent effect
If appetite suppression is insufficient at the current dose, ensure technique is correct before requesting a dose increase
A meta-analysis highlighted some impressive outcomes: an average reduction in waist circumference by 5.16 cm, a BMI drop of 2.42 points, and significant decreases in serum triglyceride levels when compared to placebo treatments
Ramezani et al., 2016
In this section, we will discuss the signs and symptoms to watch for, when to contact your doctor, and the best practices for post-vaccination care
This action can lead to more weight loss for some people